Download
17 May 2022 Development partnership with Scandinavian Realheart
29 April 2022 31 March 2022 Quarter Activity Report & Appendix 4C
7 April 2022 Prospectus - 2022 Placement Attachment Options
28 February 2022 Proposed issue of securities
28 February 2022 Investor Presentation
28 February 2022 Hydrix Completes A$2.82M Placement
31 January 2022 31 December 2021 Quarter Activity Report & Appendix 4C
26 OCTOBER 2021 Hydrix Appoints Mr Paul Lewis MBE FAICD to the Board
26 OCTOBER 2021 Letter to Shareholders - Annual General Meeting
26 OCTOBER 2021 Notice of Annual General Meeting/Proxy Form
26 OCTOBER 2021 Appendix 4G and Corporate Governance Statement
26 OCTOBER 2021 2021 Annual Report to shareholders
14 SEPTEMBER 2021 ASX Announcement - Hydrix On Track for Cardiac Product Sales in H1 CY22
31 AUGUST 2021 Letter from Executive Chairman
To view past announcements visit the Hydrix page on the ASX
For all shareholder enquiries, please contact us via the form below:
Please use the contact form below for all non-shareholders
To view the latest Hydrix share price and announcements, visit the Hydrix page on the ASX
Hydrix Executive Chairman, Gavin Coote, hosted an investor conference call to discuss financial results
Gavin Coote outlines the Hydrix's medtech-centric vision for 2022 in his latest interview with Proactive
News story on Hydrix's plans to launch the AngelMed Guardian system into the Australian market
